# Inhibikase Therapeutics, Inc.: Form 8-K, filed Jun 30, 2025

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: 8-K
- Filed: 2025-06-30
- Accepted by EDGAR: Jun 30, 2025, 16:29 ET
- Period: 2025-06-27
- Accession: 0001193125-25-152767
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000119312525152767/d109611d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000119312525152767/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000119312525152767/d109611d8k.htm

Filed Jun 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-152767. Last ingested by Listed: Nov 11, 2026, 02:12 ET. No prices; not investment advice.
